Wednesday - April 30, 2025

Eosinophilic Esophagitis Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Therapies, Prevalence, and Companies by DelveInsight

Eosinophilic Esophagitis Drugs Market Eosinophilic Esophagitis Companies are Regeneron Pharmaceuticals, Sanofi, Bristol-Myers Squibb, Ellodi Pharmaceuticals, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception Therapeutics, Celgene, Dr. Falk Pharma GmbH, Revolo Biotherapeutics, Shire, Novartis, EMS, Celgene, Oxagen Ltd, Meritage Pharma, Inc, Forest Laboratories, … Continue reading

Arteriotomy Closure Devices Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes | DelveInsight

Arteriotomy Closure Devices Market The arteriotomy closure devices market is growing steadily, driven by the rise in endovascular procedures, preference for minimally invasive interventions, and demand for quicker recovery. Advancements in closure technologies and the increasing prevalence of cardiovascular diseases … Continue reading

Neuromodulation Devices Market to Grow at a CAGR of ~8.95% by 2032, Fueled by Advancements in Neurological Therapies and Rising Prevalence of Neurological Disorders | DelveInsight

Neuromodulation Devices Market The neuromodulation devices market is growing steadily, driven by rising neurological disorders, tech advancements, and adoption of non-invasive therapies. Demand for treatments like chronic pain, Parkinson’s, and epilepsy, along with innovations in implantable and wearable devices, is … Continue reading

Bispecifics/Trispecifics Market Poised for Transformative Growth by 2035 – Insights by DelveInsight | Featuring Akeso, Summit Therapeutics & More

Bispecifics/Trispecifics Market The bispecifics/trispecifics market is driven by the need for targeted treatments in cancers like ALL, DLBCL, Follicular Lymphoma, Multiple Myeloma, NSCLC, and SCLC. These therapies improve patient outcomes by targeting multiple tumor mechanisms, offering hope for more effective … Continue reading